Roland Taylor, 69, has faced considerable struggles in life, at times battling homelessness and addiction. Two years ago, he felt a lump in his chest, but ignored it until he discovered that it had grown. He went to the doctor and was shocked to learn that he had breast cancer.
Tag: Oncology
GW Experts Are Available to Speak for Stories during Lung Cancer Awareness Month
WASHINGTON (Oct. 30, 2019) — November is Lung Cancer Awareness Month and according to the American Cancer Society, more than 220,000 new cases of lung cancer are diagnosed each year. The George Washington University (GW) Cancer Center has various experts…
How Oncologists Can Ethically Navigate the “Right-to-Try” Drug Law
The 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs that have not yet been approved by the Food and Drug Administration (FDA). Many in the oncology community say Right to Try strips away important regulatory protections and view the move as a risky step bound to create ethical dilemmas for physicians whose goal is to guide patients toward safe and appropriate treatment decisions. Oncology is one field at the forefront of requests for unapproved drugs. An interdisciplinary team of bioethicists, oncologists, and lawyers from Penn Medicine and other institutions penned a commentary published online this week in the Journal of Clinical Oncology to offer recommendations to help oncologists navigate this new “Right to Try” world, while maintaining their ethical obligations to patients.
Using Plasma Jets to Deliver Cancer Medication
Modern advances in oncology have significantly improved cancer survival rates. However, personalized treatment methods are necessary, since tumors may behave differently for different patients. At the AVS 66th International Symposium and Exhibition, Cristina Canal, a researcher at Universitat Politècnica de Catalunya, will present cold plasmas as a promising tool for minimally invasive cancer therapy. She will discuss the benefits of using plasma jets for cancer therapy, and explain the use of different liquid media, hydrogels and their properties.
Stephan Grupp, MD, PhD, Elected to the National Academy of Medicine
Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology and Director of the Cancer Immunotherapy Program at Children’s Hospital of Philadelphia, has been elected into the National Academy of Medicine (NAM), effective Oct. 1, 2019.
Developments In Breast Cancer Diagnosis By Radiation Oncologist Expert
Maria C.E. Jacobs, M.D., leads the Radiation Oncology team at Mercy Medical Center in Baltimore, Maryland. She places top priority on quality patient care, medical excellence and helping her patients get the best possible radiation therapy treatment. In her role…
Pioneering oncology researcher leads publication of new exercise prescriptions for cancer prevention, survival
Oncology nurse practitioner Anna Schwartz, a professor at Northern Arizona University, was a leader on the team that reviewed the latest scientific evidence and offered recommendations about the benefits of exercise for prevention, treatment, recovery and improved survival, which were shared this week in three publications.
Lung Cancer Program at NYU Langone Health’s Perlmutter Cancer Center Joins Prestigious Thoracic Surgery Oncology Group
NYU Langone Health has become one of 23 institutions selected to comprise the American Association for Thoracic Surgery’s Thoracic Surgery Oncology Group (TSOG). A North American thoracic surgery clinical trials network, TSOG aims to improve the understanding of thoracic oncologic diseases and enhance the care of patients.
Oncologists Respond Swiftly to FDA Safety Alerts, Penn Study Finds
Within six months of the FDA’s move to restrict the label of two immunotherapies, usage of those therapies among oncologists dropped by about 50 percent, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania.
GW Experts Available During Breast Cancer Awareness Month
WASHINGTON (Sept. 24, 2019) – Breast cancer is the second most commonly diagnosed cancer in women in the United States, with the American Cancer Society predicting more than 250,000 new cases in 2019. October is Breast Cancer Awareness Month and…
Yale Cancer Center research highlighted at ASTRO 2019
Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
Yale Cancer Center research highlighted at ASTRO 2019
Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
Cancer Predisposition Clinic Aims To Change Trajectory Of Genetically Based Cancer
Children’s of Alabama’s Cancer Predisposition Clinic physicians develop personalized screening for children who have inherited cancer predisposition syndromes with hopes that early detection will lead to improved outcomes.
Henry Ford Cancer Institute First-in-Michigan, Second-in-World to Complete Laser Spinal Ablation
Henry Ford Cancer Institute is the first-in-Michigan and second-in-the-world to complete an innovative cancer treatment known as Spinal Laser Interstitial Thermal Therapy (SLITT), which destroys cancer cells that are adjacent to the spine without the need for open surgery.
Depression, Anxiety Linked to Opioid Use in Women With Breast Cancer
The findings should encourage doctors to better manage mental health in patients with breast cancer and spur care providers to consider alternative pain management such as physical therapy, massage and acupuncture, the researchers say.
Depression, Anxiety Linked to Opioid Use in Women With Breast Cancer
The findings should encourage doctors to better manage mental health in patients with breast cancer and spur care providers to consider alternative pain management such as physical therapy, massage and acupuncture, the researchers say.